Importantly, these gut-derived insulin-producing cells were characterized by expression of β-cell maturity factors, glucose-stimulated insulin release in-vitro and were capable of reversing hyperglycemia following STZ administration in mice 47. This evidence concerns the gene INS and Hyperglycemia.